Cargando…

Attenuated Notch signaling in schizophrenia and bipolar disorder

The Notch signaling pathway plays a crucial role in neurodevelopment and in adult brain homeostasis. We aimed to further investigate Notch pathway activity in bipolar disorder (BD) and schizophrenia (SCZ) by conducting a pathway analysis. We measured plasma levels of Notch ligands (DLL1 and DLK1) us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoseth, Eva Z., Krull, Florian, Dieset, Ingrid, Mørch, Ragni H., Hope, Sigrun, Gardsjord, Erlend S., Steen, Nils Eiel, Melle, Ingrid, Brattbakk, Hans-Richard, Steen, Vidar M., Aukrust, Pål, Djurovic, Srdjan, Andreassen, Ole A., Ueland, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871764/ https://www.ncbi.nlm.nih.gov/pubmed/29593239 http://dx.doi.org/10.1038/s41598-018-23703-w

Ejemplares similares

Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder
por: Hoseth, Eva Z., et al.
Publicado: (2018)

Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting
por: Steen, Nils Eiel, et al.
Publicado: (2016)

F22. DYSLIPIDEMIA AND INFLAMMATORY MARKERS IN RELATION TO CLINICAL SYMPTOMATOLOGY IN PSYCHOTIC DISORDERS
por: Gohar, Sherif M, et al.
Publicado: (2018)

Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders
por: Gohar, Sherif M., et al.
Publicado: (2018)

Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
por: Reponen, Elina J., et al.
Publicado: (2020)

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes
por: Torsvik, Anja, et al.
Publicado: (2023)

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
por: Szabo, Attila, et al.
Publicado: (2020)

Expression of TCN1 in Blood is Negatively Associated with Verbal Declarative Memory Performance
por: Akkouh, Ibrahim A., et al.
Publicado: (2018)

S96. CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Rødevand, Linn, et al.
Publicado: (2018)

Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder
por: Fjukstad, Katrine Kveli, et al.
Publicado: (2016)

Inflammation and cognition in severe mental illness: patterns of covariation and subgroups
por: Sæther, Linn Sofie, et al.
Publicado: (2022)

Immune marker levels in severe mental disorders: associations with polygenic risk scores of related mental phenotypes and psoriasis
por: Werner, Maren Caroline Frogner, et al.
Publicado: (2022)

Childhood Trauma Is Nominally Associated With Elevated Cortisol Metabolism in Severe Mental Disorder
por: Aas, Monica, et al.
Publicado: (2020)

Composite immune marker scores associated with severe mental disorders and illness course
por: Elkjaer Greenwood Ormerod, Monica Bettina, et al.
Publicado: (2022)

Patterns of childhood adverse events are associated with clinical characteristics of bipolar disorder
por: Larsson, Sara, et al.
Publicado: (2013)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2021)

Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
por: Gjerde, Priyanthi B., et al.
Publicado: (2022)

Telomere length is associated with childhood trauma in patients with severe mental disorders
por: Aas, Monica, et al.
Publicado: (2019)

Lipid Biomarker Research in Bipolar Disorder: A Scoping Review of Trends, Challenges, and Future Directions
por: Hiller, John Kim, et al.
Publicado: (2023)

Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
por: Hjell, Gabriela, et al.
Publicado: (2023)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021)

Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids
por: Osete, Jordi Requena, et al.
Publicado: (2023)

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities
por: Steen, Nils Eiel, et al.
Publicado: (2023)

Correction: Connection between Genetic and Clinical Data in Bipolar Disorder
por: Mellerup, Erling, et al.
Publicado: (2013)

Differences in white blood cell proportions between schizophrenia cases and controls are influenced by medication and variations in time of day
por: Villar, Jonelle D., et al.
Publicado: (2023)

Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2019)

CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls
por: Tesli, Martin, et al.
Publicado: (2013)

Course of intellectual functioning in schizophrenia and bipolar disorder: a 10-year follow-up study
por: Flaaten, Camilla Bärthel, et al.
Publicado: (2023)

Exploring lithium’s transcriptional mechanisms of action in bipolar disorder: a multi-step study
por: Akkouh, Ibrahim A., et al.
Publicado: (2019)

Association between leptin levels and severity of suicidal behaviour in schizophrenia spectrum disorders
por: Gohar, S. M., et al.
Publicado: (2019)

Correction: CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls
por: Tesli, Martin, et al.
Publicado: (2013)

Characterising the shared genetic determinants of bipolar disorder, schizophrenia and risk-taking
por: Hindley, Guy, et al.
Publicado: (2021)

Combinations of genetic variants associated with bipolar disorder
por: Mellerup, Erling, et al.
Publicado: (2017)

Altered Brain Activation during Emotional Face Processing in Relation to Both Diagnosis and Polygenic Risk of Bipolar Disorder
por: Tesli, Martin, et al.
Publicado: (2015)

Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders
por: Haram, Marit, et al.
Publicado: (2015)

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
por: Kroken, Rune A., et al.
Publicado: (2019)

Genetic loci shared between major depression and intelligence with mixed directions of effect
por: Bahrami, Shahram, et al.
Publicado: (2021)

Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes
por: Rødevand, Linn, et al.
Publicado: (2021)

Combinations of SNPs Related to Signal Transduction in Bipolar Disorder
por: Koefoed, Pernille, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jgnfdp2mcuv9hhed3efk157geo